Kabeer Aziz | Partner
ADJUVANT CAPITAL

Kabeer Aziz is an investor with over a decade of experience at the intersection of finance and life sciences. With a passion for global health research & development, Kabeer co-founded Adjuvant Capital, a life sciences investment fund designed to accelerate the development of new technologies for public health challenges. Before Adjuvant, he was with the Global Health Investment Fund, where he led investments in biotech companies addressing unmet needs in infectious disease and maternal & child health. Prior to that, Kabeer spent time at Metalmark Capital investing across the healthcare sector, as well as Greenhill & Co., where he advised on biopharmaceutical M&A transactions. Kabeer is based in New York and currently represents Adjuvant on the Boards of various companies including MinervaX, LimmaTech Biologics, AN2 Therapeutics, and Pulmocide, among others. He graduated with honors from the Stern School of Business at New York University.